CRISPR Therapeutics (CRSP)
CRISPR Therapeutics (CRSP) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.
- CRSP last traded at $39.50 on 2026-11-20, 1.46% for the session.
- CRISPR Therapeutics: market cap $3.83B, revenue $25.17M over the last four quarters, next earnings 2027-02-11.
- Over the past year CRSP returned -22.14%, with a year-to-date return of -24.68%.